Joel Ackerman - 05 Nov 2021 Form 4 Insider Report for CHAMPIONS ONCOLOGY, INC. (CSBR)

Reporting relationship: Director
Issuer ticker: CSBR
Reported as of: 05 Nov 2021
Net transaction value: +$187,496
SEC form: 4
Accepted by SEC: 09 Nov 2021, 16:30:30 UTC
Prior SEC filing: 11 Aug 2021
Next SEC filing: 17 Mar 2022
Source filing: View source filing
Reporting owner signature: /s/ Joel Ackerman

Key filing fact

Joel Ackerman filed Form 4 for CHAMPIONS ONCOLOGY, INC. (CSBR) on 09 Nov 2021.

Key facts

This page summarizes Joel Ackerman's Form 4 filing for CHAMPIONS ONCOLOGY, INC. (CSBR).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 09 Nov 2021, 16:30.

Change

Previous filing in this sequence was filed on 11 Aug 2021.
Current net transaction value: +$187,496.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CSBR transaction Derivative

Option to purchase Common Stock

Award

Transaction value: $187,496
Shares: +18,564
Change %
Price: $10.10
Shares after: 18,564
Date: 05 Nov 2021
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 18,564
Exercise price: $10.10
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The options vest over a twelve month period and are exercisable over a ten year period, with vesting to occur on November 5, 2021, February 5, 2022, May 5, 2022 and August 5, 2022, respectively.